SRSD-107
- Generic Name
- SRSD-107
A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Sirius Therapeutics Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06116617
- Locations
- 🇦🇺
Linear Clinical Research, Perth, Other (Non U.s.), Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath